BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10215596)

  • 1. Expression of normal and truncated forms of human endoglin.
    Raab U; Velasco B; Lastres P; Letamendía A; Calés C; Langa C; Tapia E; López-Bote JP; Páez E; Bernabéu C
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):579-88. PubMed ID: 10215596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function.
    Paquet ME; Pece-Barbara N; Vera S; Cymerman U; Karabegovic A; Shovlin C; Letarte M
    Hum Mol Genet; 2001 Jun; 10(13):1347-57. PubMed ID: 11440987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.
    Pece N; Vera S; Cymerman U; White RI; Wrana JL; Letarte M
    J Clin Invest; 1997 Nov; 100(10):2568-79. PubMed ID: 9366572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1.
    Pece-Barbara N; Cymerman U; Vera S; Marchuk DA; Letarte M
    Hum Mol Genet; 1999 Nov; 8(12):2171-81. PubMed ID: 10545596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1.
    Ríus C; Smith JD; Almendro N; Langa C; Botella LM; Marchuk DA; Vary CP; Bernabéu C
    Blood; 1998 Dec; 92(12):4677-90. PubMed ID: 9845534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms.
    Lux A; Gallione CJ; Marchuk DA
    Hum Mol Genet; 2000 Mar; 9(5):745-55. PubMed ID: 10749981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoglin expression on human microvascular endothelial cells association with betaglycan and formation of higher order complexes with TGF-beta signalling receptors.
    Wong SH; Hamel L; Chevalier S; Philip A
    Eur J Biochem; 2000 Sep; 267(17):5550-60. PubMed ID: 10951214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways.
    Sánchez-Elsner T; Botella LM; Velasco B; Langa C; Bernabéu C
    J Biol Chem; 2002 Nov; 277(46):43799-808. PubMed ID: 12228247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Umbilical vein and placental vessels from newborns with hereditary haemorrhagic telangiectasia type 1 genotype are normal despite reduced expression of endoglin.
    Chan NL; Bourdeau A; Vera S; Abdalla S; Gross M; Wong J; Cymerman U; Paterson AD; Mullen B; Letarte M
    Placenta; 2004; 25(2-3):208-17. PubMed ID: 14972453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
    Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
    Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.
    Abdalla SA; Pece-Barbara N; Vera S; Tapia E; Paez E; Bernabeu C; Letarte M
    Hum Mol Genet; 2000 May; 9(8):1227-37. PubMed ID: 10767348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin.
    Cymerman U; Vera S; Pece-Barbara N; Bourdeau A; White RI; Dunn J; Letarte M
    Pediatr Res; 2000 Jan; 47(1):24-35. PubMed ID: 10625079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1.
    Bourdeau A; Cymerman U; Paquet ME; Meschino W; McKinnon WC; Guttmacher AE; Becker L; Letarte M
    Am J Pathol; 2000 Mar; 156(3):911-23. PubMed ID: 10702408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles.
    Gallione CJ; Klaus DJ; Yeh EY; Stenzel TT; Xue Y; Anthony KB; McAllister KA; Baldwin MA; Berg JN; Lux A; Smith JD; Vary CP; Craigen WJ; Westermann CJ; Warner ML; Miller YE; Jackson CE; Guttmacher AE; Marchuk DA
    Hum Mutat; 1998; 11(4):286-94. PubMed ID: 9554745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia.
    Llorca O; Trujillo A; Blanco FJ; Bernabeu C
    J Mol Biol; 2007 Jan; 365(3):694-705. PubMed ID: 17081563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of endoglin mRNA and protein in human vascular smooth muscle cells.
    Adam PJ; Clesham GJ; Weissberg PL
    Biochem Biophys Res Commun; 1998 Jun; 247(1):33-7. PubMed ID: 9636649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development.
    Arthur HM; Ure J; Smith AJ; Renforth G; Wilson DI; Torsney E; Charlton R; Parums DV; Jowett T; Marchuk DA; Burn J; Diamond AG
    Dev Biol; 2000 Jan; 217(1):42-53. PubMed ID: 10625534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1.
    McAllister KA; Grogg KM; Johnson DW; Gallione CJ; Baldwin MA; Jackson CE; Helmbold EA; Markel DS; McKinnon WC; Murrell J
    Nat Genet; 1994 Dec; 8(4):345-51. PubMed ID: 7894484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments.
    Pichuantes S; Vera S; Bourdeau A; Pece N; Kumar S; Wayner EA; Letarte M
    Tissue Antigens; 1997 Sep; 50(3):265-76. PubMed ID: 9331949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia.
    Bourdeau A; Faughnan ME; Letarte M
    Trends Cardiovasc Med; 2000 Oct; 10(7):279-85. PubMed ID: 11343967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.